Your browser doesn't support javascript.
loading
Treating linear porokeratosis with topical lovastatin/cholesterol cream.
Buhle, Anna C; Fagan, Kiley K; Johnson, Nathan M; Grider, Douglas J.
Afiliação
  • Grider DJ; Section of Dermatology, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA. djgrider@carilionclinic.org.
Dermatol Online J ; 28(5)2022 Oct 15.
Article em En | MEDLINE | ID: mdl-36809136
ABSTRACT
Linear porokeratosis is a rare variant of porokeratosis that is characterized by unilateral lesions along the lines of Blaschko. Like all variants of porokeratosis, linear porokeratosis is characterized by the histopathologic finding of cornoid lamellae bracketing the lesion. The underlying pathophysiology involves a two-hit post-zygotic knockdown of genes involved in mevalonate biosynthesis in embryonic keratinocytes. Although there is currently no standard or effective treatment, therapies targeted to rescue this pathway and restore keratinocyte cholesterol availability are promising. Presented here is a patient with a rare, extensive case of linear porokeratosis treated with compounded 2% lovastatin/2% cholesterol cream leading to partial resolution of the plaques.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poroceratose Limite: Humans Idioma: En Revista: Dermatol Online J Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poroceratose Limite: Humans Idioma: En Revista: Dermatol Online J Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article